Xencor (XNCR) EBT Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Xencor (XNCR) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -5,319.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 31,363.00 |
| 10 | Xencor | 2.02 Bn | 1.64 Bn | - | 1,433.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,433.00 |
| Mar 31, 2026 | -254,397.00 |
| Dec 31, 2025 | 4,256.00 |
| Sep 30, 2025 | 8,731.00 |
| Jun 30, 2025 | 2,146.00 |
| Mar 31, 2025 | -17,841.00 |
| Dec 31, 2024 | -13,189.00 |
| Sep 30, 2024 | -6,257.00 |
| Jun 30, 2024 | -30,118.00 |
| Mar 31, 2024 | -41,722.00 |
| Dec 31, 2023 | 789.00 |
| Sep 30, 2023 | -554.00 |
| Jun 30, 2023 | 21,019.00 |
| Mar 31, 2023 | -27,956.00 |
| Dec 31, 2022 | 71,594.00 |
| Sep 30, 2022 | -6,742.00 |
| Jun 30, 2022 | -1,068.00 |
| Mar 31, 2022 | -4,136.00 |
| Dec 31, 2021 | 20,482.00 |
| Sep 30, 2021 | -21,486.00 |